Huarong Kechuang Biotechnology
Surgical solutions for microsurgery, cardiac, and trauma.
About Huarong Kechuang Biotechnology
Huarong Kechuang Biotechnology, operating as Kingsung Medical Group, is a medical technology company founded in 2008. The firm centers its operations on the mission to "Simplify Surgery, Beautiful Life" by developing products across four main technology platforms: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. Its product portfolio provides solutions for microsurgery, cardiac surgery, trauma surgery, orthopedics, and innovative biomaterials. The company is positioned as a significant player in the microsurgery market and has been recognized as a National High-Tech Enterprise. Its Tianjin base serves as a hub for research and development. Kingsung Medical Group collaborates with numerous hospitals and universities, including Peking University and the Chinese University of Hong Kong, to advance its product development and clinical applications. The company actively engages with clients and partners to provide premium services and create value.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Jun 2026 | $28M | $110M | Proxima Ventures | ↗ |
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
AuST GroupMedical device design, development, and manufacturing services. |
— | Operational | 131 | — | — |
Ablaview, SLReal-time optical lesion assessment for cardiac ablation. |
Tres Cantos, Spain | Operational | |||
Ruixin Intelligent Medical TechnologyAI-powered cardiovascular diagnosis and surgical robotics. |
Shenzhen, China | Operational | |||
Blue Ridge VascularMinimally invasive vascular and endovascular surgical treatment. |
Roanoke, United States | Operational | |||
Cook FranceMinimally invasive medical devices for multiple specialities. |
Paris, France | Operational | |||
Aureus CardiovascularAdvanced cardiovascular surgery technology development and optimization. |
Jacksonville, United States | Operational | |||
NorthStar Vascular Surgery Center of TexasOutpatient vascular surgery for dialysis access care. |
— | Operational | |||
South53, LLCIntegrated devices improving vascular access procedure outcomes. |
San Juan Capistrano, United States | Operational |
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Huarong Kechuang Biotechnology in the Yueyang ecosystem
The Huarong Kechuang Biotechnology office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Proxima Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Huarong Kechuang Biotechnology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Huarong Kechuang Biotechnology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.









